Accrol Group Holdings PLC Result of AGM (9260M)
24 September 2021 - 8:59PM
UK Regulatory
TIDMACRL
RNS Number : 9260M
Accrol Group Holdings PLC
24 September 2021
24 September 2021
Accrol Group Holdings plc
("Accrol", the "Company" or the "Group")
AIM: ACRL
Result of 2021 Annual General Meeting
Accrol, the leading independent tissue converter in the UK,
announces that all of the resolutions set out in the Notice of AGM
were passed by the requisite majority at the Company's AGM, held
earlier today.
Details of the proxy votes received by the Company are as
follows:
Resolution For Against Withheld
No. of votes % No. of votes % No. of
votes
------------- ------ ------------- ------ -----------
1. To receive the Annual
Report and Accounts 173,045,052 99.97 55,500 0.03 0
------------- ------ ------------- ------ -----------
2. To appoint BDO as Auditor 172,869,183 99.97 60,369 0.03 171,000
------------- ------ ------------- ------ -----------
3. To elect Richard Newman
as a Director 172,867,430 99.87 231,622 0.13 1,500
------------- ------ ------------- ------ -----------
4. To re-elect Gareth
Jenkins as a Director 173,039,757 99.97 59,295 0.03 1,500
------------- ------ ------------- ------ -----------
5. To re-elect Daniel
Wright as a Director 146,840,485 93.80 9,701,366 6.20 16,558,701
------------- ------ ------------- ------ -----------
6. To re-elect Euan Hamilton
as a Director 168,339,194 97.25 4,759,858 2.75 1,500
------------- ------ ------------- ------ -----------
7. To approve the Directors'
Remuneration Report 146,655,287 84.73 26,439,847 15.27 5,418
------------- ------ ------------- ------ -----------
8. To approve the Dividend* 173,100,552 100 0 0 0
------------- ------ ------------- ------ -----------
9. To authorise the Directors
to allot relevant securities* 168,252,440 99.86 235,604 0.14 4,612,508
------------- ------ ------------- ------ -----------
10. To authorise the Directors
to allot equity securities
for cash without making
a pre-emptive offer to
shareholders* 172,854,258 99.86 246,294 0.14 0
------------- ------ ------------- ------ -----------
*Special resolution
Notes:
1. Proxy appointments which gave discretion to the Chairman
of the AGM have been included in
"For" total for the appropriate resolution.
2. Votes "For" and "Against" any resolution are expressed as
a percentage of votes validly cast for that resolution.
3. A "Vote withheld" is not a vote in law and is not counted
in the calculation of the percentage of shares voted "For"
or "Against".
4. The number of shares in issue on 24 September 2021 was 318,878,097
with no shares in treasury.
5. The full text of the resolutions passed at the AGM can be
found in the Notice of Annual General Meeting which is available
on the Company's website at www.accrol.co.uk .
For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman Via Belvedere Communications
Gareth Jenkins, Chief Executive Officer
Richard Newman, Chief Financial Officer
Zeus Capital Limited (Nominated Adviser
& Broker)
Dan Bate / Jordan Warburton Tel: +44 (0) 161 831 1512
Dominic King Tel: +44 (0) 203 829 5000
Liberum Capital Limited (Joint Broker) Tel: +44 (0) 20 3100 2222
Clayton Bush / Edward Thomas
Belvedere Communications Limited
Cat Valentine Tel: +44 (0) 7715 769 078
Keeley Clarke Tel: +44 (0) 7967 816 525
accrolpr@belvederepr.com
Overview of Accrol
Accrol Group Holdings plc is a leading tissue converter and
supplier of toilet tissues, kitchen rolls, facial tissues, and wet
wipes to many of the UK's leading discounters and grocery retailers
across the UK. Following the recent acquisitions of LTC in
Leicester and JD in Flint, North Wales, the Group now operates from
six manufacturing sites, including four in Lancashire, which
generate revenues totalling c.16% of the GBP2.1bn UK retail tissue
market.
For more information, please visit www.accrol.co.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGUSVRRANUKUAR
(END) Dow Jones Newswires
September 24, 2021 06:59 ET (10:59 GMT)
Accrol (LSE:ACRL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Accrol (LSE:ACRL)
Historical Stock Chart
From Apr 2023 to Apr 2024